Data / Form D filings / Arrivo BioVentures, LLC
Arrivo BioVentures, LLC: Form D filings
Arrivo BioVentures, LLC, a biotechnology company in Morrisville, NC, filed 2 Form D notices with the SEC between 2016 and 2023. The latest, on November 29, 2023, reports $43.2 million sold of a $45.3 million offering to 58 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3000 RDU Center Drive, Suite 130, Morrisville, NC, 27560
- Phone
- (919) 753-7067
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1674649
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 29, 2023 | New notice | $45,250,000 | $43,194,016 | $2,055,984 | 58 | Nov 17, 2023 | sec.gov |
| May 25, 2016 | New notice | $49,000,000 | $49,000,000 | 34 | May 10, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Karen E. Adams | Executive Officer | |
| Stephen E. Butts | Executive Officer |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Nov 27, 2023 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Arrivo BioVentures, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.